[{"id":"19b483e0-e06b-49a5-9c96-b44876659d3f","acronym":"","url":"https://clinicaltrials.gov/study/NCT05957536","created_at":"2023-07-24T15:08:43.228Z","updated_at":"2024-07-02T16:35:01.282Z","phase":"Phase 1","brief_title":"A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors","source_id_and_acronym":"NCT05957536","lead_sponsor":"D3 Bio (Wuxi) Co., Ltd","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 positive","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e D3L-001"],"overall_status":"Recruiting","enrollment":" Enrollment 110","initiation":"Initiation: 09/19/2023","start_date":" 09/19/2023","primary_txt":" Primary completion: 03/11/2026","primary_completion_date":" 03/11/2026","study_txt":" Completion: 03/11/2026","study_completion_date":" 03/11/2026","last_update_posted":"2024-05-23"}]